HMS
NKTR icon

Hanseatic Management Services’s Nektar Therapeutics NKTR Stock Holding History

Hanseatic Management Services’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-213
Closed -$156K – 418
2018
Q2 		$156K Buy
+213
New +$246K 0.13% 130
2015
Q1 		– Sell
-162
Closed -$38K – 361
2014
Q4 		$38K Buy
+162
New +$34.6K 0.02% 181

Other funds holding NKTR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Hanseatic Management Services's NKTR Position: Q3 2018 in Review

Hanseatic Management Services sold out of Nektar Therapeutics (NKTR) in Q3 2018, closing a stake of 213 shares — an estimated $156K sold.

Hanseatic Management Services first reported a position in NKTR in Q4 2014 and held it in 2 quarters. The position peaked at $156K in Q2 2018. 388 funds tracked by Wall St. Rank hold NKTR as of Q3 2018.

  • Hanseatic Management Services reported no remaining Nektar Therapeutics position as of Q3 2018 after selling out during the quarter.
  • Hanseatic Management Services sold 213 Nektar Therapeutics shares in Q3 2018, an estimated $156K.
  • Hanseatic Management Services first reported a position in Nektar Therapeutics in Q4 2014 and held it in 2 quarters.
  • Hanseatic Management Services's Nektar Therapeutics position peaked at $156K in Q2 2018.
  • 388 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q3 2018.

Based on Hanseatic Management Services's 13F filing for Q3 2018, filed 14 Nov 2018.